Dr Edward Wang



Projects as PI
Go to first page Go to previous page 1 of 2 Go to next page Go to last page

Cellular and viral immunology resource - Funder:Medical Research Council (23/04/2006 - 22/01/2010)
Characterisation of a novel class of natural killer cell immunoevasin - Funder:Medical Research Council (01/08/2020 - 31/07/2023)
Commercial supply of DR3 Knock out - Funder:Cancer Research Technology Ltd (01/04/2015 - 29/02/2016)
DR3 knockout - Funder:Cancer Research Technology Ltd (01/08/2012 - 31/07/2013)


Projects as Co-Investigator
Go to first page Go to previous page 4 of 4 Go to next page Go to last page

Targeting CD200 signalling to overcome cell carcinoma immune evasion - Funder:British Skin Foundation (01/01/2014 - 31/07/2017)
The role of antibody in enabling cell-mediated control of HCMV infection - Funder:Medical Research Council (01/04/2019 - 31/03/2022)

Last updated on 2020-09-08 at 04:02